<DOC>
	<DOCNO>NCT01845272</DOCNO>
	<brief_summary>This study designate evaluate pharmacokinetic interaction candesartan cilexetil amlodipine besylate healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Candesartan Cilexetil Amlodipine Besylate</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male volunteer age 20 55 year old ( inclusive ) Body mass index ( BMI ) range 18.5 27 kg/m2 ( inclusive ) Available entire study period Understand requirement study voluntarily consent participate study Subjects history gastrointestinal disease might significantly change ADME medicine Systolic blood pressure outside range 100 150 mmHg diastolic blood pressure outside range 60 1000 mmHg male subject . screen period Subject symptoms acute disease within 14days prior study medication dose Subjects history clinically significant allergy Subjects hereditary problem , example , galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption Subjects whose clinical laboratory test value outside accept normal range ( Especially , AST ALT &gt; 1.5 time normal range total bilirubin &gt; 1.5times normal range ) History drug abuse History caffeine , alcohol , smoke abuse caffeine ( coffee , tea , coke ) grapefruit juice &gt; 4cups/day smoking &gt; 20 cigarettes/day alcohol &gt; 140g/week Positive test result HBs Ab , HCV Ab , Syphilis regain test Participation clinical investigation within 30days prior study medication dose Subjects whole blood donation within 60days , component blood donation within 30days blood transfusion within 30days prior study medication dose Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>